BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 34482632)

  • 1. Role of the MOZ/MLL-mediated transcriptional activation system for self-renewal in normal hematopoiesis and leukemogenesis.
    Yokoyama A
    FEBS J; 2022 Dec; 289(24):7987-8002. PubMed ID: 34482632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukemogenesis via aberrant self-renewal by the MLL/AEP-mediated transcriptional activation system.
    Yokoyama A
    Cancer Sci; 2021 Oct; 112(10):3935-3944. PubMed ID: 34251718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of CpG-Rich Promoters Mediated by MLL Drives MOZ-Rearranged Leukemia.
    Miyamoto R; Okuda H; Kanai A; Takahashi S; Kawamura T; Matsui H; Kitamura T; Kitabayashi I; Inaba T; Yokoyama A
    Cell Rep; 2020 Sep; 32(13):108200. PubMed ID: 32997997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosstalk between leukemia-associated proteins MOZ and MLL regulates HOX gene expression in human cord blood CD34+ cells.
    Paggetti J; Largeot A; Aucagne R; Jacquel A; Lagrange B; Yang XJ; Solary E; Bastie JN; Delva L
    Oncogene; 2010 Sep; 29(36):5019-31. PubMed ID: 20581860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The mechanism of MLL-rearranged leukemogenesis and its targeted therapies].
    Yokoyama A
    Rinsho Ketsueki; 2021; 62(8):988-997. PubMed ID: 34497239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of the histone acetyltransferase monocytic leukemia zinc finger protein in normal and malignant hematopoiesis.
    Katsumoto T; Yoshida N; Kitabayashi I
    Cancer Sci; 2008 Aug; 99(8):1523-7. PubMed ID: 18754862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symplekin, a polyadenylation factor, prevents MOZ and MLL activity on HOXA9 in hematopoietic cells.
    Largeot A; Paggetti J; Broséus J; Aucagne R; Lagrange B; Martin RZ; Berthelet J; Quéré R; Lucchi G; Ducoroy P; Bastie JN; Delva L
    Biochim Biophys Acta; 2013 Dec; 1833(12):3054-3063. PubMed ID: 23994619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MOZ is essential for maintenance of hematopoietic stem cells.
    Katsumoto T; Aikawa Y; Iwama A; Ueda S; Ichikawa H; Ochiya T; Kitabayashi I
    Genes Dev; 2006 May; 20(10):1321-30. PubMed ID: 16702405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MOZ is critical for the development of MOZ/MLL fusion-induced leukemia through regulation of Hoxa9/Meis1 expression.
    Katsumoto T; Ogawara Y; Yamagata K; Aikawa Y; Goitsuka R; Nakamura T; Kitabayashi I
    Blood Adv; 2022 Oct; 6(19):5527-5537. PubMed ID: 35947126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HBO1-MLL interaction promotes AF4/ENL/P-TEFb-mediated leukemogenesis.
    Takahashi S; Kanai A; Okuda H; Miyamoto R; Komata Y; Kawamura T; Matsui H; Inaba T; Takaori-Kondo A; Yokoyama A
    Elife; 2021 Aug; 10():. PubMed ID: 34431785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of MLL-associated leukemia.
    Yokoyama A
    Int J Hematol; 2015 Apr; 101(4):352-61. PubMed ID: 25773519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MORF and MOZ acetyltransferases target unmethylated CpG islands through the winged helix domain.
    Becht DC; Klein BJ; Kanai A; Jang SM; Cox KL; Zhou BR; Phanor SK; Zhang Y; Chen RW; Ebmeier CC; Lachance C; Galloy M; Fradet-Turcotte A; Bulyk ML; Bai Y; Poirier MG; Côté J; Yokoyama A; Kutateladze TG
    Nat Commun; 2023 Feb; 14(1):697. PubMed ID: 36754959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MOZ and MORF, two large MYSTic HATs in normal and cancer stem cells.
    Yang XJ; Ullah M
    Oncogene; 2007 Aug; 26(37):5408-19. PubMed ID: 17694082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The histone acetyl transferase activity of monocytic leukemia zinc finger is critical for the proliferation of hematopoietic precursors.
    Perez-Campo FM; Borrow J; Kouskoff V; Lacaud G
    Blood; 2009 May; 113(20):4866-74. PubMed ID: 19264921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional activation by MLL fusion proteins in leukemogenesis.
    Yokoyama A
    Exp Hematol; 2017 Feb; 46():21-30. PubMed ID: 27865805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromodomain-PHD finger protein 1 is critical for leukemogenesis associated with MOZ-TIF2 fusion.
    Shima H; Yamagata K; Aikawa Y; Shino M; Koseki H; Shimada H; Kitabayashi I
    Int J Hematol; 2014 Jan; 99(1):21-31. PubMed ID: 24258712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The stem cell factor SALL4 is an essential transcriptional regulator in mixed lineage leukemia-rearranged leukemogenesis.
    Yang L; Liu L; Gao H; Pinnamaneni JP; Sanagasetti D; Singh VP; Wang K; Mathison M; Zhang Q; Chen F; Mo Q; Rosengart T; Yang J
    J Hematol Oncol; 2017 Oct; 10(1):159. PubMed ID: 28974232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MYSTerious MOZ, a histone acetyltransferase with a key role in haematopoiesis.
    Perez-Campo FM; Costa G; Lie-a-Ling M; Kouskoff V; Lacaud G
    Immunology; 2013 Jun; 139(2):161-5. PubMed ID: 23347099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes.
    Ullah M; Pelletier N; Xiao L; Zhao SP; Wang K; Degerny C; Tahmasebi S; Cayrou C; Doyon Y; Goh SL; Champagne N; Côté J; Yang XJ
    Mol Cell Biol; 2008 Nov; 28(22):6828-43. PubMed ID: 18794358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MOZ and BMI1 act synergistically to maintain hematopoietic stem cells.
    Sheikh BN; Metcalf D; Voss AK; Thomas T
    Exp Hematol; 2017 Mar; 47():83-97.e8. PubMed ID: 27773671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.